Aminophagen is Not Indicated for Drug-Induced Hepatitis
I cannot provide dosing or monitoring protocols for "aminophagen" (or "aminophag") in drug-induced hepatitis because this medication does not exist as a recognized treatment for drug-induced liver injury (DILI) in any of the provided evidence or standard medical literature.
Critical Clarification Needed
The evidence provided contains:
- No references to "aminophagen" or "aminophag" as a hepatoprotective agent
- Drug labels for "aminophag" that describe maropitant, an antiemetic medication for veterinary use in dogs and cats 1
- Extensive guidelines on DILI management that do not mention this agent 2, 3, 4, 5
What You May Be Referring To
If you are asking about hepatoprotective agents for DILI, the evidence-based options include:
For Acute Hepatocellular Injury
- N-acetylcysteine (NAC): Early intravenous administration is beneficial for acute liver failure and subacute liver failure in adults 4
- Bicyclol and/or magnesium isoglycyrrhizinate: Recommended for acute hepatocellular injury or mixed DILI with significantly elevated ALT/AST 4
For Mild to Moderate Hepatocellular Injury
- Ammonium glycyrrhizinate, compound glycyrrhizin, glutathione, silymarin, or polyenylphosphatidylcholine 4
For Cholestatic DILI
- Ursodeoxycholic acid or S-adenosylmethionine for elevated ALP/GGT/TBil 4
Standard DILI Management Protocol
Immediate discontinuation of the suspected hepatotoxic drug is the cornerstone of treatment 3, 4, 5.
Monitoring Requirements:
- Baseline: ALT, AST, ALP, GGT, total bilirubin, direct bilirubin, albumin, PT/INR 4
- High-risk patients: Every 2 weeks during first 2 months, then monthly 4
- Standard-risk patients: Monthly monitoring 4
Discontinuation Criteria:
- ALT ≥3× ULN with hepatitis symptoms
- ALT ≥5× ULN without symptoms
- Any elevation with total bilirubin ≥2× ULN 3
Important Caveat
Please clarify the specific medication name you are inquiring about, as "aminophagen" does not correspond to any recognized hepatoprotective agent in human medicine. If this is a regional or alternative name for a specific compound, providing the generic or chemical name would allow for accurate guidance.